SRPX2 and pulmonary fibrosis: Collectively, our data support the notion that Srpx2 plays a critical role in the progression of pulmonary fibrosis and the liposomes-based strategy aiming at silencing Srpx2 could be a viable therapeutic approach against pulmonary fibrosis in clinical settings.